AI offers promise in the realm of chronic disease management, including diabetes, obesity, and PCOS, but must be approached with caution.

ENDO 2025 spotlights breakthrough research in PCOS, obesity, diabetes, and rare endocrine disorders and offers practical updates for daily clinical care. As the sun rises over San Francisco, ...

Endocrine Society experts encouraged more widespread screening for a common hormonal cause of high blood pressure known as ...

Chronic kidney disease is a progressive, irreversible decline in kidney function lasting over three months. Causes include diabetes, hypertension, and autoimmune diseases. Symptoms develop gradually ...

A novel AI-powered retina tracker can analyze retinal images with near-perfect accuracy in under one second, according to a ...

The National Organization for Rare Disorders (NORD®) is honoring a distinguished group of industry leaders and individuals for their contributions to help improve the lives of more than 30 million ...

New research identifies diabetes as an independent predictor of major adverse cardiovascular events in patients with both ...

Endocrine Society experts encouraged more widespread screening for a common hormonal cause of high blood pressure known as ...

A new Scientific Statement released today by the Endocrine Society highlights potential research directions related to the pathogenesis of type 1 diabetes (T1D) that should help with the development ...

A new study has found that exposure to military burn pits increases the risk of mental health conditions and brain injuries, ...

Focus is on pathogenesis, but the document also highlights the clinical areas of type 1 diabetes heterogeneity and screening for early-stage disease.